[1] SALEH AH,SAMUEL N,JURASCHKA K,et al.The biology of ependymomas and emerging novel therapies [J].Nature Reviews Cancer,2022,22(4):208-222.
[2] SCHAFF LR,MELLINGHOFF IK.Glioblastoma and other primary brain malignancies in adults:a review [J].Jama,2023,329(7):574-587.
[3] PASKEH MDA,MEHRABI A,GHOLAMI MH,et al.EZH2 as a new therapeutic target in brain tumors:Molecular landscape,therapeutic targeting and future prospects [J].Biomedicine & Pharmacotherapy,2022,146:112532.
[4] AUBIN RG,TROISI EC,MONTELONGO J,et al.Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma [J].Nature Communications,2022,13(1):3936.
[5] LIAO C,AN J,YI S,et al.FUT8 and protein core fucosylation in tumours:from diagnosis to treatment [J].Journal of Cancer,2021,12(13):4109-4120.
[6] PENG D,FU M,WANG M,et al.Targeting TGF-β signal transduction for fibrosis and cancer therapy [J].Molecular Cancer,2022,21(1):104.
[7] ZENG C,HE R,DAI Y,et al.Identification of TGF-β signaling-related molecular patterns,construction of a prognostic model,and prediction of immunotherapy response in gastric cancer [J].Frontiers in Pharmacology,2022,13:1069204.
[8] RIDDER DA,URBANSKY LL,WITZEL HR,et al.Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma,mediates tumor progression,and predicts unfavorable outcome [J].Cancers,2022,14(2):430.
[9] TAURIELLO DVF,SANCHO E,BATLLE E.Overcoming TGFβ-mediated immune evasion in cancer [J].Nature Reviews Cancer,2022,22(1):25-44.
[10] LI S,LIU M,DO MH,et al.Cancer immunotherapy via targeted TGF-β signalling blockade in T(H) cells [J].Nature,2020,587(7832):121-125.
[11] WU MZ,YUAN YC,HUANG BY,et al.Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis [J].Signal Transduction and Targeted Therapy,2021,6(1):395.
[12]刘晨,隋红.TGF-β信号通路介导胃癌EMT的研究进展[J].现代肿瘤医学,2020,28(03):517-520.
LIU Chen,SUI Hong.Research progress on TGF-β signaling pathway in mediating EMT of gastric cancer[J].Modern Oncology,2020,28(03):517-520.
[13]王春刚,陈山,王志峰,等.长链非编码RNA LIMT调控TGF-β信号通路对肺癌细胞增殖与凋亡的影响[J].现代肿瘤医学,2020,28(18):3108-3113.
WANG Chungang,CHEN Shan,WANG Zhifeng,et al.Effect of long non-coding RNA LIMT regulating TGF-β signaling pathway on proliferation and apoptosis of lung cancer cells[J].Modern Oncology,2020,28(18):3108-3113.
[14] JANG E,SHIN MK,KIM H,et al.Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells [J].Experimental & Molecular Medicine,2023,55(5):974-986.
[15] OLBRECHT S,BUSSCHAERT P,QIAN J,et al.High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing:specific cell subtypes influence survival and determine molecular subtype classification [J].Genome Medicine,2021,13(1):111.
[16] ZUO H,YANG D,WAN Y.Fam20C regulates bone resorption and breast cancer bone metastasis through osteopontin and BMP4 [J].Cancer Research,2021,81(20):5242-5254.
[17] FERNANDEZ-SEVILLA LM,VALENCIA J,ORTIZ-SANCHEZ P,et al.High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes [J].Blood,2022,139(22):3303-3313.
[18] WANG Z,CHEN W,ZUO L,et al.The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells [J].Cancer Communications (London,England),2022,42(3):245-265.
[19] WANG X,SHI X,LU H,et al.Succinylation inhibits the enzymatic hydrolysis of the extracellular matrix protein fibrillin 1 and promotes gastric cancer progression [J].Advanced Science (Weinheim,Baden-Wurttemberg,Germany),2022,9(27):e2200546.
[20] JEONG SM,BUI QT,KWAK M,et al.Targeting Cdc20 for cancer therapy [J].Biochimica et Biophysica Acta Reviews on Cancer,2022,1877(6):188824.
[21] CHEN OJ,CASTELLSAGUE E,MOUSTAFA-KAMAL M,et al.Germline missense variants in CDC20 result in aberrant mitotic progression and familial cancer [J].Cancer Research,2022,82(19):3499-3515.
[22] GABITOVA-CORNELL L,SURUMBAYEVA A,PERI S,et al.Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer [J].Cancer Cell,2020,38(4):567-583.e11.
[23] XU J,SHAO T,SONG M,et al.MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer [J].Molecular Cancer,2020,19(1):51.